Percentage of positive biopsy cores as a predictor of clinical outcome in prostate cancer treated with radiotherapy

Journal of Urology

Volumn 168, Issue 5, 2002, Pages 1994-1999

  Kestin, Larry L ^a   Goldstein, Neal S ^a   Vicini, Frank A ^a   Martinez, Alvaro A ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

Biopsy; Brachytherapy; Prostate specific antigen; Prostatic neoplasms; Radiotherapy

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PATHOLOGY; PELVIS; PERINEURIUM; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CARCINOMA; RADIATION DOSE; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0036837489     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64280-2     Document Type: Article

References (25)

1. Catalona, W. J. and Smith, D. S.: Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol, 160: 2428, 1998
2. Oefelein, M. G., Smith, N. D., Grayhack, J. T., Schaeffer, A. J. and McVary, K. T.: Long-term results of radical retropubic prostatectomy in men with high grade carcinoma of the prostate. J Urol, 158: 1460, 1997
3. D'Amico, A. V.: Combined-modality staging for localized adenocarcinoma of the prostate. Oncology, 15: 1049, 2001
4. Epstein, J. I.: The role of perineural invasion and other biopsy characteristics as prognostic markers for localized prostate cancer. Semin Urol Oncol, 16: 124, 1998
5. D'Amico, A. V., Whittington, R., Malkowicz, S. B., Schultz, D., Fondurulia, J., Chen, M. H. et al: Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer. J Clin Oncol, 18: 1164, 2000
6. D'Amico, A. V., Schultz, D., Silver, B., Henry, L., Hurwitz, M., Kaplan, I. et al: The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys, 49: 679, 2001
7. Freedland, S. J., Csathy, G. S., Dorey, F. and Aronson, W. J.: Percent prostate needle biopsy tissue with cancer is more predictive of biochemical failure or adverse pathology after radical prostatectomy than prostate specific antigen or Gleason score. J Urol, 167: 516, 2002
8. Presti, J. C., Jr., Shinohara, K., Bacchetti, P., Tigrani, V. and Bhargava, V.: Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology, 52: 1079, 1998
9. American Joint Committee on Cancer: Prostate. In: AJCC Cancer Staging Manual, 4th ed. Edited by O. H. Beahrs, D. E. Henson, R. V. P. Hutter and B. J. Kennedy. Philadelphia: Lippincott-Raven, chapt. 31, p. 181, 1992
10. Kestin, L. L., Martinez, A. A., Stromberg, J. S., Edmundson, G. K., Gustafson, G. S., Brabbins, D. S. et al: Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer. J Clin Oncol, 18: 2869, 2000
11. Martinez, A. A., Kestin, L. L., Stromberg, J. S., Gonzalez, J. A., Wallace, M., Gustafson, G. S. et al: Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial. Int J Radiat Oncol Biol Phys, 47: 343, 2000
12. Brenner, D. J., Martinez, A. A., Edmundson, G. K., Mitchell, C., Thames, H. D. and Armour, E. P.: Direct evidence that prostate tumors show high sensitivity to fractionation (low alpha/ beta ratio), similar to late-responding normal tissue. Int J Radiat Oncol Biol Phys, 52: 6, 2002
13. Kestin, L. L., Vicini, F. A., Ziaja, E. L., Stromberg, J. S., Frazier, R. C. and Martinez, A. A.: Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy. Cancer, 86: 1557, 1999
14. Martinez, A. A., Gonzalez, J. A., Chung, A. K., Kestin, L. L., Balasubramaniam, M., Diokno, A. C. et al: A comparison of external beam radiation therapy versus radical prostatectomy for patients with low risk prostate carcinoma diagnosed, staged, and treated at a single institution. Cancer, 88: 425, 2000
15. Vicini, F. A., Kestin, L. L. and Martinez, A. A.: The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma. Cancer, 88: 2305, 2000
16. Bostwick, D. G.: Staging prostate cancer-1997: current methods and limitations. Eur Urol, 32: 2, 1997
17. Narayan, P., Gajendran, V., Taylor, S. P., Tewari, A., Presti, J. C., Jr., Leidich, R. et al: The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer. Urology, 46: 205, 1995
18. Tiguert, R., Gheiler, E. L., Grignon, D. J., Littrup, P. J., Sakr, W., Pontes, J. E. et al: Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors. J Urol, 163: 1486, 2000
19. Peller, P. A., Young, D. C., Marmaduke, D. P., Marsh, W. L. and Badalament, R. A.: Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens. Cancer, 75: 530, 1995
20. Sebo, T. J., Cheville, J. C., Riehle, D. L., Lohse, C. M., Pankratz, V. S., Myers, R. P. et al: Predicting prostate carcinoma volume and stage at radical prostatectomy by assessing needle biopsy specimens for percent surface area and cores positive for carcinoma, perineural invasion, Gleason score, DNA ploidy and proliferation, and preoperative serum prostate specific antigen: a report of 454 cases. Cancer, 91: 2196, 2001
21. Bostwick, D. G., Qian, J., Bergstralh, E., Dundore, P., Dugan, J., Myers, R. P. et al: Prediction of capsular perforation and seminal vesicle invasion in prostate cancer. J Urol, 155: 1361, 1996
22. Ravery, V., Boccon-Gibod, L. A., Dauge-Geffroy, M. C., Billebaud, T., Delmas, V., Meulemans, A. et al: Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy. Urology, 44: 371, 1994
23. Ackerman, D. A., Barry, J. M., Wicklund, R. A., Olson, N. and Lowe, B. A.: Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy. J Urol, 150: 1845, 1993
24. Naughton, C. K., Smith, D. S., Humphrey, P. A., Catalona, W. J. and Keetch, D. W.: Clinical and pathologic tumor characteristics of prostate cancer as a function of the number of biopsy cores: a retrospective study. Urology, 52: 808, 1998
25. Naughton, C. K., Miller, D. C., Mager, D. E., Ornstein, D. K. and Catalona, W. J.: A prospective randomized trial comparing 6 versus 12 prostate biopsy cores: impact on cancer detection. J Urol, 164: 388, 2000